TickerFacts.

Compare

Tactile Systems Technology Inc vs Angiodynamics Inc vs PROCEPT BioRobotics Corp vs SkinHealth Systems Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearTactile Systems Technology Inc
TCMD		Angiodynamics Inc
ANGO		PROCEPT BioRobotics Corp
PRCT		SkinHealth Systems Inc.
SKIN
Year ended2025-12-312026-05-312025-12-312025-12-31
Revenue$329.52M$320.17M$308.05M$300.79M
Revenue growth (YoY)+12.5%+9.5%+37.2%-10.0%
Gross margin75.9%54.6%63.7%65.3%
Operating margin8.9%-12.5%-33.7%-6.9%
Net margin5.8%-11.5%-31.0%-3.2%
Net income$19.09M-$36.74M-$95.57M-$9.52M
EPS (Diluted)$0.82-$0.88-$1.72-$0.16
Operating cash flow$42.81M$3.09M-$48.98M$37.48M
Free cash flow$40.43M$508.0K-$58.34M$37.18M
Cash & equivalents$83.45M$53.86M$286.50Mn/a
Total assets$273.94M$267.16M$508.08M$499.80M
Total liabilities$55.04M$96.34M$142.21M$438.75M
Shareholders' equity$218.90M$170.82M$365.87M$61.06M
Return on year-end equity8.7%-21.5%-26.1%-15.6%
Shares outstanding22.44M41.70M56.32M127.52M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearTactile Systems Technology IncAngiodynamics IncPROCEPT BioRobotics CorpSkinHealth Systems Inc.
Latest$329.52M
Ended 2025-12-31		$320.17M
Ended 2026-05-31		$308.05M
Ended 2025-12-31		$300.79M
Ended 2025-12-31
1 year earlier$292.98M
Ended 2024-12-31		$292.50M
Ended 2025-05-31		$224.50M
Ended 2024-12-31		$334.29M
Ended 2024-12-31
2 years earlier$274.42M
Ended 2023-12-31		$303.91M
Ended 2024-05-31		$136.19M
Ended 2023-12-31		$397.99M
Ended 2023-12-31
3 years earlier$246.78M
Ended 2022-12-31		$338.75M
Ended 2023-05-31		$75.01M
Ended 2022-12-31		$365.88M
Ended 2022-12-31
4 years earlier$208.06M
Ended 2021-12-31		$316.22M
Ended 2022-05-31		$34.47M
Ended 2021-12-31		$260.09M
Ended 2021-12-31